Study of the effect of Atomoxetine in comparison with placebo on cognitive symptoms in patients with schizophrenia

Mashhad University of Medical Sciences0 sites42 target enrollmentTBD

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Not specified
Sponsor: Mashhad University of Medical Sciences
Enrollment: 42
Status: Recruiting
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Mashhad University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

•2nd Generation Antipsychotic Drug use
•Lack of dementia
•Not taking other medicines (except anticholinergics and benzodiazepines)
•No pregnancy or breastfeeding
•There is no recent history of drugs (except nicotine)
•schizophrenic patients during partial recovery

Exclusion Criteria

•Drug side effects including: abdominal discomfort, loss of appetite resulting in weight loss, dizziness, irritability and mood swings
•Occurrence of drug interactions with patient medications

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Phase 3

Study of therapeutic effects of Atomoxtein in reducing the symptoms of patients with recurrent vasovagal syncope

IRCT20180125038507N1Tehran University of Medical Sciences50

Recruiting

Phase 2

Effectiveness of Atomoxetine treatment for methamphetamine use disorderOther stimulants dependence syndrome.Dependence syndrome: A cluster of behavioral, cognitive, and physiological phenomena that develop after repeated substance use and that typically include a strong desire to take the drug, difficulties in controlling its use, persisting in its use despiteF15.24

IRCT2017070234844N1Tehran University of Medical Sciences (TUMS), Vice-chancellor for Research90

Not yet recruiting

Phase 3

Atomoxetine for cognitive impairment in Behcet's disease

IRCT20211206053288N1Tehran University of Medical Sciences40

Recruiting

Phase 3

Evaluating the effect of Atomoxetine and Oxybutynin combination on the number of apnea in obstructive sleep apnea patients referring to the sleep clinics of Tehran University of Medical SciencesObstructive Sleep Apnea.Obstructive sleep apnea (adult) (pediatric)G47.33

IRCT20220201053905N1Tehran University of Medical Sciences18

Active, not recruiting

Phase 1

Evaluation of the effect of Atomoxetine on impulsive state of High impulsive Tourette’s patients.

EUCTR2019-004455-36-FRCHU DE POITIERS45